Bradley J Monk, MD, FACOG, FACS

Professor
Email Address: 
Phone Number: 
(602) 406-7730
FAX: 
(602) 798-0807

UACC Information

UACC Organizational Unit: 
Professional Bio: 

Dr. Monk is a Professor and Director of the Division of Gynecologic Oncology at Creighton University School of Medicine at St. Joseph’s Hospital and Medical Center in Phoenix, Arizona. He received his medical degree from the University of Arizona, College of Medicine in Tucson. His clinical interests include the prevention and chemotherapy of gynecologic malignancies and quality of life aspects of cancer care.

Dr. Monk has coauthored more than 230 articles in peer-reviewed journals such as New England Journal of Medicine, Journal of Clinical Oncology, and Clinical Cancer Research. He is a member of the American Society of Clinical Oncology, NRG Oncology and American Society of Clinical Oncology.

Dr. Monk currently serves on the Scientific Review Committee at the University of Arizona Cancer Center.

Research Information

Research Program: 
Therapeutic Development
Member Status: 
Associate Research Member
Year of Membership Acceptance: 
2012
Collaborative Research: 
Ongoing:
MORAb 003-004                     (Monk, PI)                                                         07/27/15-Present
Morphotek
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Assess the Efficacy and Safety of Farletuzumab (MORAb-003) in Combination with Paclitaxel or Carboplatin plus PLD in Subjects with Low CA-125 Platinum Sensitive Ovarian Cancer.                                                
                       
PR-30-5011-C                        (Monk, PI)                                                         11/22/13-Present
TESARO,Inc
A Phase 3 Randomized Double-Blind Trial of Maintenance with Niraparib Versus Placebo in Patients with Platinum Sensitive Ovarian Cancer. NOVA.                                               
 
ARAY 162-311                        (Monk, PI)                                                         07/22/13-Present
Array BioPharma Inc.
A Multinational, Randomized, Open-Label Phase 3 Study of MEK162 vs. Physician’s Choice Chemotherapy in Patients with Recurrent or Persistent Low-grade Serous Carcinomas of the Ovary, Fallopian Tube or Primary Peritoneum                                                    
 
I1D-MC-JIAE                            (Monk, PI)                                                         12/13/12-Present
Eli Lilly
A Randomized, Double-Blind, Placebo-Controlled Phase 1b/2 Study of LY2228820, a p38 MAPK Inhibitor, plus Gemcitabine and Carboplatin versus Gemcitabine and Carboplatin for Women with Platinum-Sensitive Ovarian Cancer                                          
 
 2009 0508                              (Monk, PI)                                                         03/07/11-Present
Amgen     
A Phase 3, Randomized, Double-Blind Trial of Weekly Paclitaxel Plus AMG 386 or Placebo in Women with Recurrent Partially Platinum Sensitive or Resistant Epithelial Ovarian, Primary Peritoneal or Fallopian Tube Cancers        
Role: Chair of Global Steering Committee                 
 
NRG-GOG                               (Monk, PI)                                                           04/01/07-03/31/16
NRG Oncology
NRG Oncology/GOG Group Cervix Committee Chair           
 
Completed:
5R21 CA156032                     (Tewari, PI)                                                         01/01/11-12/31/15
NIH/NCI
Novel Biologic Markers of Treatment Resistance in Locally Advanced Cervical Carcinoma
Role: Co-Principal Investigator
 
130/070                                 (Monk, PI)                                                          04/27/12-05/08/15
Genentech
A Multicenter, Observational, Prospective Study of Platinum Sensitive Ovarian Cancer Patients After First Recurrence – PRECISION                                  
 
BKM120                                  (Monk, PI)                                                          05/06/11-05/28/14
Novartis
A Phase II, Single-arm Study of Orally Administered BKM120 as Second-line Therapy in Patients with Advanced Endometrial Carcinoma                               
 
ET743-SAR-3007                   (Monk, PI)                                                          09/27/12-12/05/14
Janssen Research & Development
A Randomized Controlled Study of YONDELIS® (Trabectedin) or Dacarbazin for the Treatment of Advanced Liposarcoma or Leiomyosarcoma – ET743-SAR-3007    
 
PIM4972g                               (Monk, PI)                                                           02/10/12-12/09/13
Genentech
A Multicenter, Single-Arm, Open-Label, Phase II Study of GDC-0980 for the Treatment of Recurrent or Persistent Endometrial Carcinoma – PIM4972g           

Professional Information

Positions and Honors: 
Academic Appointments:
2012-present   Professor, Clinical Scholar Track, Department of Obstetrics and Gynecology, University of Arizona College of Medicine - Phoenix
2011-present   Director, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, St. Joseph’s Hospital and Medical Center
2010-present   Professor, Department of Obstetrics and Gynecology, Creighton University School of Medicine
2004-2010      Associate Professor, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of California, Irvine Medical Center
1998-2004      Assistant Professor, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of California, Irvine Medical Center
1997-1998      Assistant Professor, Department of General Surgery, Division of Urology, Texas Tech University Health Sciences Center, Lubbock Campus
1995-1998      Assistant Professor, Department of Obstetrics and Gynecology, Director, Division of Gynecologic Oncology, Texas Tech University Health Sciences Center, Lubbock Campus
1992-1995      Clinical Instructor, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of California, Irvine Medical Center
 
Non-Academic Appointments:
2010-present   Gynecologic Oncologist, St. Joseph’s Hospital and Medical Center
2007-2010      Director Research, Division of Gynecologic Oncology, Chao Family Comprehensive Cancer Center, UCI Medical Center
2004-2005      Member, Cancer Center Translational Seed Grant Review Committee, Chao Family Comprehensive Cancer Center, UCI Medical Center
2004-2005      Member, Dean’s Scientific Review Committee, University of California, Irvine
2004-2005      Co-Chair, Cancer Center Clinical Trials Protocol Review and Monitoring Committee, Chao Family Comprehensive Cancer Center, UCI Medical Center
2001-2005      Member of the College of Medicine Representative Assembly OB/GYN, University of California, Irvine
2000-present   Member, University of California, Irvine, Ob/Gyn Educational Committee
2000-present   Member of UCI Medical Center Cancer Committee
2000-present   Director, University of California, Irvine, Department of Obstetrics and Gynecology, Annual Resident Paper Day
2000-present   Course Coordinator, Department of Obstetrics and Gynecology, Annual Philip J. DiSaia Society Symposium
2000-2004      Chairman, University of California, Irvine, College of Medicine Promotions and Honors Committee  (re-elected 2 times)
2000-2001      Member of the UCI Medical Center, Clinical Research Planning Committee
1999-present   Member, University of California, Irvine, Department of Obstetrics and Gynecology Residency Selection Committee
1996-1998      Co-Director, Gynecologic Oncology/Radiation Oncology Clinics, Joe Arrington Cancer Center
1996-1998      Associate Medical Director, Southwest Cancer Center, University Medical Center
 
Honors:
2013                Ernst Wertheim Award, Austrian Association of Gynecologic Oncology, Salzburg, Austria
2012-2013      Top Doctor, Phoenix, Arizona, Published in PHOENIX magazine
2011-2012      Best Doctors in America, Best Doctors, Inc., Aiken South Carolina
2009-2010      Physician of Excellence, Orange County Medical Association, Orange, California
2007-2008      Best Doctors in America®, Best Doctors, Inc., Boston, Massachusetts
2007                Physician of Excellence, Orange County Medical Association, Orange, California
2006-2007      60th Diamond Edition of Who’s Who in America, Marquis Who’s Who®, New Providence, New Jersey
2006                Physician of Excellence, Orange County Medical Association, Orange, California
2005-2006      Best Doctors in America, Best Doctors, Inc., Aiken South Carolina
2003                Recipient of an Award of Excellence in the Presentation of the End of Life Care Content.  Palliative Care and Quality of Life, in Clinical Gynecologic Oncology 6th Edition. DiSaia & Creasman Eds, Mosby, Inc. 2002
Other Experience and Professional Memberships/Affiliations: 
2010-Present   Fellow, American Gynecological Obstetrical Society
1999-Present   Member, Society of Surgical Oncology
1999-Present   Member, Society of Gynecologic Oncologists (SGO)
1999-Present   Fellow, American College of Surgeons (FACS)
1998-Present   Fellow, American College of Obstetrics and Gynecology (FACOG)
1997-Present   Member, Western Association of Gynecologic Oncology (WAGO)
1997-Present   Member, American Medical Association (AMA)
1996-Present   Member, American Society of Clinical Oncology (ASCO)
1996-Present   Member, American Association for Cancer Research (AACR)
1996-Present   Fellow, American Society for Colposcopy and Cervical Pathology (FASCCP)
1995-Present   Member, Association of Professors of Gynecology and Obstetrics
1995-Present   Investigator, Gynecologic Oncology Group (GOG)
1992-Present   Member, Daniel Morton Society
1992-Present   Member, American Association of Gynecologic Laparoscopists

Academic Information

Fellowship: 
National Institutes of Health (NIH), Bethesda, MD; M.D. Anderson Cancer Center, Houston, TX; University of California, Irvine, Orange, CA
Residency: 
University of California, Los Angeles, Los Angeles, CA
Medical School: 
University of Arizona College of Medicine, Tucson, AZ
Undergraduate School: 
Brigham Young University, Provo, Utah